2017•PubMedRequires access

Smoking Cessation Drugs: A Summary for Dental Professionals.

David I Tindle

Abstract

Currently, seven pharmaceutical products are approved by the United States Food and Drug Administration for smoking cessation. Five of these are nicotine replacement products. The remaining two are the non-nicotine containing medications varenicline and bupropion. This paper provides a summary of these smoking cessation pharmaceuticals for dental health professionals.

About this research paper

What this paper is about

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Key concepts: Varenicline, Bupropion, Smoking cessation, Medicine, Food and drug administration, Nicotine replacement therapy, Nicotine, Health professionals